Rachel Brazil is a science writer based in London, UK
The under-representation of women in clinical trials is slowly being addressed, but we cannot move towards truly personalised healthcare unless we have an equal balance of the sexes in all new medicine trials.
Incidence of sexually transmitted infections is increasing and antimicrobial resistance is adding fuel to the fire, particularly in the case of gonorrhoea. In response, researchers are working on three major strategies to help reduce its spread and maintain susceptibility to antibiotics.
Smaller, smarter and more sensitive — how four new technologies could change the way drugs are monitored and administered.
Stopping whooping cough in its tracksSubscription
Binning the sharps: the quest for oral insulinSubscription
Photopharmacology: using light to activate drugsSubscription